ImmunoGuide® Enzyme immunoassay (ELISA) for the determination of free Cetuximab (Erbitux®) in serum and plasma.<br><br>
The drug Cetuximab (trade name Erbitux®) is a human-mouse chimeric immunoglobulin (Ig) G1ƙ monoclonal antibody (mAb), selectively directed against the epidermal growth factor receptor (EGFR), also known as HER1 or ErbB1. Since its approval by Food and Drug Administration for cancer treatment in 2004, Cetuximab became widely used in the treatment of colorectal and head and neck cancers.<br><br>
The ImmunoGuide Cetuximab ELISA (mAb-based) kit can be efficiently used for measuring free Cetuximab levels in serum and plasma. For research use only, not for use in diagnostic procedures.
- Assay Description:
- 1 hour incubation (RT) + 30 min. (RT) + 10 min. (RT) = 1 hour, 40 min. total incubation time
- Catalog number:
- TM09026
- configuration:
- 96 Determinations, 12x8 removable strips
- controls:
- None provided
- design:
- Enzyme immunoassay (ELISA) technique
- FDA Status:
- For research use only, not for use in diagnostic procedures
- MSDS:
- Available upon request
- notes:
- The protocol for this product (see above) is intended to serve as an example only. Please refer to the Instructions For Use provided with the assay kit for precise details.
- Other names:
- Erbitux®
- Protocol:
- Sample types:
- Serum and plasma
- Sample volume:
- 10 µL
- standards:
- 5 standards, concentrated
- Standard range:
- 0 / 6.0 - 200.0 ng/mL
- storage:
- 2 - 8 °C
- sensitivity:
- 2 ng/mL
- Species:
- Human
- Products related:
- Anti-Cetuximab (Erbitux®) ELISA
- Additional info:
